Lipocine Inc. — Investor Relations & Filings
Lipocine Inc. is a clinical-stage biopharmaceutical company that develops treatments for metabolic, endocrine, and central nervous system disorders. The company leverages its proprietary Lip'ral drug delivery technology to enhance the oral absorption of water-insoluble drugs, aiming to improve patient compliance and therapeutic outcomes. Its portfolio includes TLANDO®, an FDA-approved oral testosterone replacement therapy. Lipocine's development pipeline features candidates for conditions such as non-alcoholic steatohepatitis (NASH), postpartum depression, obesity, and prevention of preterm birth. The company's strategy often involves using the 505(b)(2) regulatory pathway to develop improved formulations of established drugs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-26 | English | |
| 8-K | 2026-05-19 | English | |
| 8-K | 2026-05-18 | English | |
| 8-K - Lipocine Inc. (0001535955) (Filer) | 2026-05-07 | English | |
| 10-Q - Lipocine Inc. (0001535955) (Filer) | 2026-05-07 | English | |
| DEF 14A - Lipocine Inc. (0001535955) (Filer) | 2026-04-21 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47073822 | 8-K | 2026-05-26 | English | ||
| 46538676 | 8-K | 2026-05-19 | English | ||
| 46385479 | 8-K | 2026-05-18 | English | ||
| 42975254 | 8-K - Lipocine Inc. (0001535955) (Filer) | 2026-05-07 | English | ||
| 42970442 | 10-Q - Lipocine Inc. (0001535955) (Filer) | 2026-05-07 | English | ||
| 34932534 | DEF 14A - Lipocine Inc. (0001535955) (Filer) | 2026-04-21 | English | ||
| 33160863 | 8-K - Lipocine Inc. (0001535955) (Filer) | 2026-04-02 | English | ||
| 33160633 | 8-K - Lipocine Inc. (0001535955) (Filer) | 2026-04-02 | English | ||
| 32893563 | 8-K - LIPOCINE INC. (0001535955) (Filer) | 2026-03-04 | English | ||
| 32893564 | 8-K - LIPOCINE INC. (0001535955) (Filer) | 2026-02-18 | English | ||
| 32893562 | 8-K - LIPOCINE INC. (0001535955) (Filer) | 2026-02-18 | English | ||
| 30451875 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30451877 | 8-K Filing | 2026-01-20 | English | ||
| 12525159 | 8-K | 2026-01-12 | English | ||
| 30451878 | 8-K Filing | 2026-01-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Altimmune, Inc.
Clinical-stage biopharma developing peptide therapeutics fo…
|
ALT | US | Manufacturing |
|
Alto Neuroscience, Inc.
Develops precision medicines for neuropsychiatric condition…
|
ANRO | US | Manufacturing |
|
ALUMIS INC.
Clinical-stage biopharma developing precision medicines for…
|
ALMS | US | Manufacturing |
|
Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosim…
|
ALVO | LU | Manufacturing |
|
ALX ONCOLOGY HOLDINGS INC
Clinical-stage immuno-oncology company developing therapies…
|
ALXO | US | Manufacturing |
|
Alzamend Neuro, Inc.
Develops treatments for neurodegenerative diseases and psyc…
|
ALZN | US | Manufacturing |
|
Alzinova AB
Clinical-stage biopharma developing immunotherapies for Alz…
|
ALZ | SE | Manufacturing |
|
Amanta Healthcare Limited
Manufactures sterile liquid formulations using advanced Blo…
|
AMANTA | IN | Manufacturing |
|
AMARIN CORP PLC\UK
Develops and commercializes therapeutics to improve cardiov…
|
AMRN | US | Manufacturing |
|
Ambalal Sarabhai Enterprise Ltd.
Manufactures pharmaceuticals, APIs, fine chemicals, and dia…
|
AMBALALSA | IN | Manufacturing |
Lipocine Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35074/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35074 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35074 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35074 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35074}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Lipocine Inc. (id: 35074)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.